In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001
about
Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal modelsThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsSB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in ratsSelective corticotropin-releasing factor type 1 receptor antagonist blocks conditioned fear-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats.
P2860
In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
In vitro pharmacological profi ...... tagonists, CRA1000 and CRA1001
@ast
In vitro pharmacological profi ...... tagonists, CRA1000 and CRA1001
@en
In vitro pharmacological profi ...... tagonists, CRA1000 and CRA1001
@nl
type
label
In vitro pharmacological profi ...... tagonists, CRA1000 and CRA1001
@ast
In vitro pharmacological profi ...... tagonists, CRA1000 and CRA1001
@en
In vitro pharmacological profi ...... tagonists, CRA1000 and CRA1001
@nl
prefLabel
In vitro pharmacological profi ...... tagonists, CRA1000 and CRA1001
@ast
In vitro pharmacological profi ...... tagonists, CRA1000 and CRA1001
@en
In vitro pharmacological profi ...... tagonists, CRA1000 and CRA1001
@nl
P2093
P1476
In vitro pharmacological profi ...... tagonists, CRA1000 and CRA1001
@en
P2093
A Nakazato
K Tomisawa
Y Hamajima
P304
P356
10.1016/S0014-2999(99)00120-X
P407
P577
1999-04-29T00:00:00Z